| abstract |
The present invention relates to a monoclonal antibody directed against human LDL receptor (Low Density Lipoprotein), binding to peptide corresponding to amino acids 195-222 (SEQ ID NO: 1) of the sequence peptidic LDL receptor, its use as a medicament, a pharmaceutical composition containing this antibody, as well as its use in immunohistochemical analyzes of cancerous tissue, whether healthy or cirrhosis, western blot, ELISA or in vivo quantification test. |